Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects
Study Identifier
P16-052
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female & Male
Age
18 - 99 Years
Protocol Summary
The objective of this study is to evaluate the safety profile of Adalimumab for Hidradenitis Suppurativa (HS) participants in normal medical practice.
Study Locations
Location
Status
Location
Kyungpook National Univ Hosp /ID# 162930
Daegu, Daegu Gwang Yeogsi, Republic of Korea, 41944
Status
Not applicable
Location
Seoul National Univ Bundang ho /ID# 202254
Seongnam, Gyeonggido, Republic of Korea, 13620
Status
Not applicable
Location
CHA Bundang Medical center, CHA University /ID# 203364
Seongnam-si, Gyeonggido, Republic of Korea, 13496
Status
Not applicable
Location
Ajou University Hospital /ID# 163243
Suwon, Gyeonggido, Republic of Korea, 16499
Status
Not applicable
Location
Chonnam National University Hospital /ID# 162932
Gwangju, Jeonranamdo, Republic of Korea, 61469
Status
Not applicable
Location
Yonsei University Health System, Severance Hospital /ID# 162933
Seodaemun-gu, Seoul Teugbyeolsi, Republic of Korea, 03722
Status
Not applicable
Showing {first} - {last} of {total} Results